Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Insulin Glargine MeSH Descriptor Data 2026


MeSH Heading
Insulin Glargine
Tree Number(s)
D06.472.699.587.200.300.100
D12.644.548.586.200.300.100
Unique ID
D000069036
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069036
Scope Note
A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.
Entry Term(s)
A21-Gly-B31-Arg-B32-Arg-insulin
Basaglar
Glargine
HOE 901
HOE-901
Insulin Glargine-aglr
Insulin Glargine-yfgn
Insulin, Gly(A21)-Arg(B31,B32)
Insulin, Glycyl(A21)-Arginyl(B31,B32)
Lantus
Lantus Solostar
Rezvoglar
Semglee
Pharm Action
Hypoglycemic Agents
Registry Numbers
2ZM8CX04RZ
0
Related Numbers
160337-95-1
Public MeSH Note
2016; INSULIN GLARGINE was indexed under INSULIN, LONG ACTING 2011-2015; and under INSULIN 1997-2011
History Note
2016 (1997)
Date Introduced
2016/01/01
Last Updated
2022/04/13
Insulin Glargine Preferred
HOE 901 Narrower
Lantus Narrower
Basaglar Narrower
Semglee Related
Insulin Glargine-aglr Narrower
page delivered in 0.128s